| 000 | 00866 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516084027.0 | ||
| 264 | 0 | _c20120724 | |
| 008 | 201207s 0 0 spa d | ||
| 022 | _a1576-6578 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSanz-Granda, A | |
| 245 | 0 | 0 |
_a[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain]. _h[electronic resource] |
| 260 |
_bRevista de neurologia _cApr 2012 |
||
| 300 |
_a446-7; author reply 447-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 700 | 1 | _aGarcia-Jurado, L | |
| 700 | 1 | _aPolanco-Sanchez, C | |
| 773 | 0 |
_tRevista de neurologia _gvol. 54 _gno. 7 _gp. 446-7; author reply 447-8 |
|
| 999 |
_c21654503 _d21654503 |
||